Literature DB >> 12382164

Ethylmalonic encephalopathy: further clinical and neuroradiological characterization.

Salvatore Grosso1, Rosa Mostardini, Maria Angela Farnetani, Massimo Molinelli, Rosario Berardi, Carlo Dionisi-Vici, Cristiano Rizzo, Guido Morgese, Paolo Balestri.   

Abstract

Ethylmalonic encephalopathy (EE) is a rare metabolic disorder with an autosomal recessive mode of inheritance that is clinically characterized by neuromotor delay, hyperlactic acidemia, recurrent petechiae, orthostatic acrocyanosis, and chronic diarrhea. Increased urinary levels of ethylmalonic acid and methylsuccinic acid are the main biochemical features of the disorder. We report on two patients affected by EE who showed different clinical and neuroradiological patterns. Patient 1 presented with a chronic clinical course characterized by very slow neuromotor deterioration, ataxia, and dysarthria. In contrast, patient 2 had an acute neonatal onset with severe neuromotor retardation, severe generalized hypotonia, and intractable seizures. Neuroradiological follow-up of patient 1 detected a diffuse hyperintensity on the T2 images at the basal ganglia which remained stable during a period of four years. Patient 2, in contrast, showed a rapid process of cerebral, and in part, cerebellar atrophy. On the basis of our observations, we reviewed the data published in the literature and tried to delineate the natural history of EE, which appears to be characterized by a wide spectrum of severity in the clinical course. No reports on neuroradiological follow-up of EE patients are available in the literature with which to compare our data. Finally, both patients showed a muscle COX deficiency. The pathogenetic implications of such a biochemical finding will be also discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12382164     DOI: 10.1007/s00415-002-0880-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  12 in total

1.  Multiple sources of metabolic disturbance in ETHE1-related ethylmalonic encephalopathy.

Authors:  Magalie Barth; Chris Ottolenghi; Laurence Hubert; Dominique Chrétien; Valérie Serre; Stéphanie Gobin; Stéphane Romano; Anne Vassault; Aziz Sefiani; Daniel Ricquier; Nathalie Boddaert; Michèle Brivet; Yves de Keyzer; Arnold Munnich; Marinus Duran; Daniel Rabier; Vassili Valayannopoulos; Pascale de Lonlay
Journal:  J Inherit Metab Dis       Date:  2010-10-27       Impact factor: 4.982

2.  Evidence that Thiosulfate Inhibits Creatine Kinase Activity in Rat Striatum via Thiol Group Oxidation.

Authors:  Mateus Grings; Belisa Parmeggiani; Alana Pimentel Moura; Leonardo de Moura Alvorcem; Angela T S Wyse; Moacir Wajner; Guilhian Leipnitz
Journal:  Neurotox Res       Date:  2018-07-28       Impact factor: 3.911

Review 3.  Acrocyanosis: the Flying Dutchman.

Authors:  Andrew K Kurklinsky; Virginia M Miller; Thom W Rooke
Journal:  Vasc Med       Date:  2011-03-22       Impact factor: 3.239

4.  Successful treatment of a patient with ethylmalonic encephalopathy by intravenous N-acetylcysteine.

Authors:  Mustafa Kılıç; Özge Dedeoğlu; Rahşan Göçmen; Selman Kesici; Deniz Yüksel
Journal:  Metab Brain Dis       Date:  2016-11-09       Impact factor: 3.584

Review 5.  Disruption of mitochondrial homeostasis in organic acidurias: insights from human and animal studies.

Authors:  Moacir Wajner; Stephen I Goodman
Journal:  J Bioenerg Biomembr       Date:  2011-02       Impact factor: 2.945

6.  Acute and Chronic Management in an Atypical Case of Ethylmalonic Encephalopathy.

Authors:  Thomas M Kitzler; Indra R Gupta; Bradley Osterman; Chantal Poulin; Yannis Trakadis; Paula J Waters; Daniela C Buhas
Journal:  JIMD Rep       Date:  2018-10-23

7.  Morphologic evidence of diffuse vascular damage in human and in the experimental model of ethylmalonic encephalopathy.

Authors:  Carla Giordano; Carlo Viscomi; Maurizia Orlandi; Paola Papoff; Alberto Spalice; Alberto Burlina; Ivano Di Meo; Valeria Tiranti; Vincenzo Leuzzi; Giulia d'Amati; Massimo Zeviani
Journal:  J Inherit Metab Dis       Date:  2011-10-22       Impact factor: 4.982

8.  Severe early onset ethylmalonic encephalopathy with West syndrome.

Authors:  Laura Papetti; Giacomo Garone; Livia Schettini; Carla Giordano; Francesco Nicita; Paola Papoff; Massimo Zeviani; Vincenzo Leuzzi; Alberto Spalice
Journal:  Metab Brain Dis       Date:  2015-07-21       Impact factor: 3.584

9.  Crystal structure of human persulfide dioxygenase: structural basis of ethylmalonic encephalopathy.

Authors:  Ilaria Pettinati; Jürgen Brem; Michael A McDonough; Christopher J Schofield
Journal:  Hum Mol Genet       Date:  2015-01-16       Impact factor: 6.150

10.  Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein.

Authors:  Valeria Tiranti; Pio D'Adamo; Egill Briem; Gianfrancesco Ferrari; Rossana Mineri; Eleonora Lamantea; Hanna Mandel; Paolo Balestri; Maria-Teresa Garcia-Silva; Brigitte Vollmer; Piero Rinaldo; Si Houn Hahn; James Leonard; Shamima Rahman; Carlo Dionisi-Vici; Barbara Garavaglia; Paolo Gasparini; Massimo Zeviani
Journal:  Am J Hum Genet       Date:  2004-01-19       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.